Your email has been successfully added to our mailing list.

×
0 0 0 0.00286673192560479 0.00069920290868406 0.0186337575164312 0.0211159278422599 0.0215354495874702
Stock impact report

Xenon Pharmaceuticals Inc. (XENE) Discusses Positive Top Line Results from Phase 3 X-TOLE2 Study of Azetukalner in Focal Onset Seizures Transcript [Seeking Alpha]

Stifel Financial Corporation (SF) 
Last stifel financial corporation earnings: 7/30 06:00 am Check Earnings Report
US:NYSE Investor Relations: stifel.com/investor-relations
Company Research Source: Seeking Alpha
Company Participants Colleen Alabiso Ian Mortimer - President, CEO, Principal Accounting Officer & Director Christopher Kenney - Chief Medical Officer Darren Cline - Chief Commercial Officer and Member of Executive Team Conference Call Participants Paul Matteis - Stifel, Nicolaus & Company, Incorporated, Research Division Tessa Romero - JPMorgan Chase & Co, Research Division Brian Abrahams - RBC Capital Markets, Research Division Lin Tsai - Jefferies LLC, Research Division Brian Skorney - Robert W. Baird & Co. Incorporated, Research Division Myles Minter - William Blair & Company L.L.C., Research Division Joseph Thome - TD Cowen, Research Division Presentation Operator Good morning, ladies and gentlemen, and thank you for standing by. My name is Kelvin, and I will be your conference operator today. At this time, I would like to welcome everyone to the Xenon Pharmaceuticals Phase III X-TOLE2 study top line results. [Operator Instructions] I would now li Show less Read more
Impact Snapshot
Event Time:
SF
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for SF alerts
Opt-in for
SF alerts

from News Quantified
Opt-in for
SF alerts

from News Quantified